RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > China Announces Electronic Monitoring Deadlines for Imported Drugs

China Announces Electronic Monitoring Deadlines for Imported Drugs

Posted 20 May 2013 | By Louise Zornoza

The China Food and Drug Administration (CFDA) has issued a notice setting deadlines for implementing electronic monitoring for imported essential drugs.

Imported drugs in domestic packaging must comply with electronic monitoring requirements by the end of November 2013, and all other imported drugs by the end of March 2014. The implementation of electronic monitoring is to be done in accordance with the former State Food and Drug Administration notice "on the issuance of guidance on electronic drug supervision." (State Food and Drug Administration [2010] No. 283)

 

© 2022 Regulatory Affairs Professionals Society.